MYD88 and hepatocellular carcinoma: Downstream of TLR4 and MyD88, activated NF-κB can bind the SAA3 promoter [31] and has been shown to regulate SAA3 transcription in hepatoma-derived cell lines and mouse adipocytes [23], [31], [32].